Hepatitis :: Abbott, Enanta to Develop and Commercialize HCV Protease Inhibitors

Abbott and Enanta Pharmaceuticals announced today that the companies have signed a worldwide agreement to develop and commercialize hepatitis C virus (HCV) NS3 and NS3/4A protease inhibitors. Enanta has discovered several HCV protease inhibitors that have demonstrated attractive efficacy and pharmacokinetic profiles in pre-clinical studies.

Homeopathy :: Non linearity straightens prescribing

In my extremely petite professional years, I have often heard the notion that in homoeopathic parlance, the sickness is basically the derangement of harmonious flow in the sensations of vital principle, whereby the disease producing micro-organisms and the likes of them are nothing- nihilist.

Growing catalysts

Porous materials are involved in many chemical reactions that affect our daily lives. Despite their wide use, there is little knowledge about them. Scientists from the Netherlands, United Kingdom and the ESRF have just shed new light on how these materials organise themselves when they are created.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack